Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 110 results for "Chronic Lymphocytic Leukemia (CLL)".

Thumbnail for Investigating National Trends and Geographic Disparities in Cardiovascular Disease-Related Mortality Among Older Adults With Hematologic Malignancies in the United States: A Comprehensive Longitudinal Analysis, 1999-2024

CLL - 1445

Investigating National Trends and Geographic Disparities in Cardiovascular Disease-Related Mortality Among Older Adults With Hematologic Malignancies in the United States: A Comprehensive Longitudinal Analysis, 1999-2024

Avinash Nankani

Poster Presenter: Avinash Nankani

Thumbnail for Cardiovascular Safety of Next-Generation BTK Inhibitors Versus Ibrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis of Randomized Phase 3 Trials

CLL - 1449

Cardiovascular Safety of Next-Generation BTK Inhibitors Versus Ibrutinib in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: A Systematic Review and Meta-Analysis of Randomized Phase 3 Trials

Allah Dad

Poster Presenter: Allah Dad

Previous 1 2 3 4 5 6 7 8...13 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Pirtobrutinib vs Idelalisib Plus Rituximab in Chronic Lymphocytic Leukemia: A Propensity-Matched Real-World Analysis

CLL - 1456

Pirtobrutinib vs Idelalisib Plus Rituximab in Chronic Lymphocytic Leukemia: A Propensity-Matched Real-World Analysis

Ahmed Abbasi

Poster Presenter: Ahmed Abbasi

$Thumbnail for A Normally Composed but Functionally Silenced NK Cell Compartment Defines Double-Refractory Chronic Lymphocytic Leukemia and Rationalizes NK-Engaging Therapies$

CLL - 1489

A Normally Composed but Functionally Silenced NK Cell Compartment Defines Double-Refractory Chronic Lymphocytic Leukemia and Rationalizes NK-Engaging Therapies

Richard I Lewis

Poster Presenter: Richard I Lewis

Thumbnail for Continuous Cumulative Exposure to Covalent BTK Inhibitors and the Nonlinear Acceleration of Incident Atrial Fibrillation in Chronic Lymphocytic Leukemia: A Primary Restricted Cubic Spline Meta-Analysis

CLL - 1494

Continuous Cumulative Exposure to Covalent BTK Inhibitors and the Nonlinear Acceleration of Incident Atrial Fibrillation in Chronic Lymphocytic Leukemia: A Primary Restricted Cubic Spline Meta-Analysis

Raj Nandan Chennuri

Poster Presenter: Raj Nandan Chennuri

Thumbnail for BTK Inhibitors Versus Venetoclax and Obinutuzumab in Anticoagulated Chronic Lymphocytic Leukemia Patients: A Propensity-Matched Analysis of Bleeding Outcomes

CLL - 1503

BTK Inhibitors Versus Venetoclax and Obinutuzumab in Anticoagulated Chronic Lymphocytic Leukemia Patients: A Propensity-Matched Analysis of Bleeding Outcomes

Vedant Shah

Poster Presenter: Vedant Shah

Thumbnail for Real-World Overall Survival, Richter's Transformation, and Secondary Primary Malignancy Rates in CLL being treated with Fixed-Duration Venetoclax-Based Therapy vs. Indefinite BTK Inhibitor Monotherapy: A TriNetX Propensity-Matched Analysis

CLL - 1511

Real-World Overall Survival, Richter's Transformation, and Secondary Primary Malignancy Rates in CLL being treated with Fixed-Duration Venetoclax-Based Therapy vs. Indefinite BTK Inhibitor Monotherapy: A TriNetX Propensity-Matched Analysis

Avi Harisingani

Poster Presenter: Avi Harisingani

$Thumbnail for Predicting Tolerance and Responses to BTKi in CLL Patients with Treatment-Naοve or Relapsed/Refractory Disease Using Pharmacogenomics$

CLL - 1544

Predicting Tolerance and Responses to BTKi in CLL Patients with Treatment-Naοve or Relapsed/Refractory Disease Using Pharmacogenomics

Fahmin Basher

Poster Presenter: Fahmin Basher

Thumbnail for Survival Trends and Prevalence Disparities in Large Granular Lymphocytic Leukemia: A Multivariate Population Based Retrospective Study.

CLL - 1546

Survival Trends and Prevalence Disparities in Large Granular Lymphocytic Leukemia: A Multivariate Population Based Retrospective Study.

Hassan Ali

Poster Presenter: Hassan Ali

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors